Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Delays Action On Amgen’s Nplate

Apr 08 2008

• By Randall Osborne

Related Content

FDA Panel Backs Amgen’s Nplate For Chronic Immune Thrombocytopenic Purpura

Mar 12 2008

Entereg User Fee Date Pushed Back To May

Feb 08 2008

GSK/Adolor's Entereg Eligible For Approval, But Lacks Proper Risk Management Plan, Advisory Panel Says

Jan 23 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window